The National Cancer Institute (NCI) is offering a grant for innovative technologies aimed at addressing pre-analytical degradation of targeted analytes in cancer-relevant biospecimens. This grant supports the development of tools, devices, and methods to enhance the quality and utility of biospecimens for downstream analyses. By focusing on sample quality preservation and verification criteria, these technologies aim to accelerate research in cancer biology, early detection, clinical diagnosis, and treatment. This opportunity is part of NCI’s Innovative Molecular Analysis Technologies (IMAT) Program. Applications should propose exploratory research projects that contribute to improving the handling and storage of biospecimens for cancer research.
Opportunity ID: 271184
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-15-004 |
| Funding Opportunity Title: | Innovative Technologies for Cancer-Relevant Biospecimen Science (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 08, 2015 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 22, 2015 |
| Current Closing Date for Applications: | Sep 22, 2015 |
| Archive Date: | Oct 23, 2015 |
| Estimated Total Program Funding: | $1,200,000 |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Special district governments State governments Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) City or township governments For profit organizations other than small businesses County governments Small businesses Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects on the inception and early-stage development of technologies that address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and storage of cancer-relevant biospecimens. The overall goal is to support the development of highly innovative technologies capable of interrogating and/or maximizing the quality and utility of biospecimens or samples derived from those biospecimens for downstream analyses. This FOA will support the development of tools, devices, instrumentation, and associated methods to assess sample quality, preserve/protect sample integrity, and establish verification criteria for quality assessment/quality control and handling under diverse conditions. These technologies are expected to potentially accelerate and/or enhance research in cancer biology, early detection, screening, clinical diagnosis, treatment, epidemiology, and cancer health disparities, by reducing pre-analytical variations that affect biospecimen sample quality.
This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-15-004.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-C | FORMS-C | PKG00211471 | Feb 17, 2015 | Sep 22, 2015 | View |
Package 1
Mandatory forms
271184 RR_SF424_2_0-2.0.pdf
271184 PHS398_ResearchPlan_2_0-2.0.pdf
271184 PHS398_CoverPageSupplement_2_0-2.0.pdf
271184 RR_KeyPersonExpanded_2_0-2.0.pdf
271184 RR_OtherProjectInfo_1_3-1.3.pdf
271184 PerformanceSite_2_0-2.0.pdf
Optional forms
271184 RR_SubawardBudget30_1_3-1.3.pdf
271184 PlannedReport-1.0.pdf
271184 PHS398_CumulativeInclusionReport-1.0.pdf
271184 PHS398_ModularBudget_1_2-1.2.pdf
271184 RR_Budget_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
